$RCEL News

TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $14

BTIG Maintains Buy on AVITA Medical, Raises Price Target to $11

AVITA Medical Announces PermeaDerm-I Study Met Primary Endpoint, Delivering Clinically Comparable Outcomes To Cadaveric Allograft With 70% Cost Reduction

BTIG Upgrades AVITA Medical to Buy, Announces $7 Price Target

AVITA Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation

Avita Medical (NASDAQ:RCEL) Beats Q2 Estimates and Raises Full-Year Guidance

AVITA Medical Raises FY2026 Sales Guidance from $80.000M-$85.000M to $86.000M-$89.000M vs $82.350M Est

AVITA Medical Q2 EPS $(0.25) Beats $(0.29) Estimate, Sales $21.702M Beat $20.167M Estimate

Avita Medical (RCEL) Upgraded to Buy: Here's Why

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

AVITA Medical to Host Investor Webinar Briefing

Lake Street Upgrades AVITA Medical to Buy, Raises Price Target to $6

AVITA Medical, Inc. Q1 2026 Earnings Call Summary

AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...

Avita Medical Q1 Earnings Call Highlights

AVITA Medical (NASDAQ:RCEL) Q1 2026 Revenue Beat Fails to Offset Wider Loss, Stock Still Rises on Outlook

AVITA Medical Reports First Quarter 2026 Financial Results

AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript

AVITA Medical Affirms FY2026 Sales Guidance of $80.000M-$85.000M vs $82.258M Est

AVITA Medical Q1 EPS $(0.35) Misses $(0.28) Estimate, Sales $19.251M Beat $18.175M Estimate